MITOFINITY™, a postbiotic from our proprietary Next-Generation probiotic strain Parabacteroides goldsteinii RV-01, is designed to support mitochondrial health and cellular vitality, backed by robust in-vivo and mechanistic data with over 15 years of RD.
Key benefits supported by animal and mechanistic studies include:
(1) Enhanced mitochondrial activity and mitophagy
(2) Strengthens antioxidant capacity and cellular resilience
(3) Modulation of inflammation via TLR4-biased immune signaling
(4) Improves gut-barrier integrity and systemic metabolic markers.
MITOFINITY™ engages multiple longevity-related pathways—including SIRT1—and demonstrates coordinated benefits across inflammation, gut health, muscle function, and mitochondrial performance. Safety evaluation is supported by genomic analysis, OECD-compliant toxicology studies, and GRAS self-affirmation for the underlying strain.
*These statements have not been evaluated by U.S FDA. This product is not intended to diagnose, treat, cure or prevent any disease.